---
author:
  - name: Dr. Scott Rader
    url: 'http://blog.stratasys.com/author/scott-rader/'
    avatar: {}
related: []
publisher:
  url: 'http://blog.stratasys.com'
  name: Stratasys Blog
  favicon: 'http://blog.stratasys.com/favicon.ico'
  domain: blog.stratasys.com
keywords:
  - printing
  - regulatory
  - manufacturing
  - products
  - fda
  - medical
  - patient-specific
  - additive
  - processes
  - stratasys
description: >-
  This post is the first in a two-part series. Over the past year, my email
  inbox has been consistently pinged by law firms advertising seminars and
  workshops that promise to help medical professionals understand what is
  noteworthy for 3D printed medical products, ranging from regulatory to IP
  concerns.
inLanguage: en
app_links: []
isBasedOnUrl: 'http://blog.stratasys.com/2016/08/15/3d-printed-medical-products-regulations/'
title: >-
  The Evolving Regulatory Landscape of 3D Printed Medical Products - Stratasys
  Blog
datePublished: '2016-08-25T15:19:41.915Z'
dateModified: '2016-08-25T15:19:32.602Z'
via: {}
starred: false
sourcePath: >-
  _posts/2016-08-25-the-evolving-regulatory-landscape-of-3d-printed-medical-prod.md
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>The Evolving Regulatory Landscape of 3D Printed Medical Products - Stratasys Blog</h1><p>This post is the first in a two-part series. Over the past year, my email inbox has been consistently pinged by law firms advertising seminars and workshops that promise to help medical professionals understand what is noteworthy for 3D printed medical products, ranging from regulatory to IP concerns.</p><img src="http://blog.stratasys.com/wp-content/uploads/2016/02/Orthotics_opt.jpg" /></article>